Dapagliflozin-13C6

MedChem Express

Dapagliflozin-13C6

5

Research Use Only

C1513C6H25ClO6

414.83

Dapagliflozin-13C6 (BMS-512148-13C6) is 13C labeled Dapagliflozin. Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine[1]. Dapagliflozin induces HIF1 expression and attenuates renal IR injury[2].

O[C@@H]1[C@@H](C2=CC(C[13C]3=[13C]([H])[13C]([H])=[13C]([13C]([H])=[13C]3[H])OCC)=C(C=C2)Cl)O[C@H]([C@@H]([C@H]1O)O)CO

12352200